Tejara Capital Ltd Makes New Investment in Pediatrix Medical Group, Inc. $MD

Key Points

• Tejara Capital Ltd acquired 50,000 shares of Pediatrix Medical Group, Inc. (NYSE:MD) for approximately $724,000, representing a 0.06% stake in the company.
• Pediatrix Medical Group reported earnings of $0.53 per share for the last quarter, surpassing analyst expectations of $0.42, although revenue declined 7.1% year-over-year.
• Institutional investors own about 97.71% of Pediatrix Medical Group’s stock, indicating strong institutional interest in the company.

Tejara Capital Ltd acquired a new stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 50,000 shares of the company's stock, valued at approximately $724,000. Tejara Capital Ltd owned 0.06% of Pediatrix Medical Group as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its holdings in Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares during the period. Tower Research Capital LLC TRC raised its holdings in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares during the last quarter. Squarepoint Ops LLC acquired a new position in shares of Pediatrix Medical Group during the 4th quarter worth $132,000. Sherbrooke Park Advisers LLC acquired a new position in shares of Pediatrix Medical Group during the 4th quarter worth $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new position in shares of Pediatrix Medical Group during the 1st quarter worth $159,000. Institutional investors and hedge funds own 97.71% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. UBS Group lifted their target price on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Macquarie boosted their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, Zacks Research raised shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $16.75.

Pediatrix Medical Group Trading Down 1.3%

Shares of NYSE MD traded down $0.2140 on Wednesday, reaching $16.2760. 704,196 shares of the company traded hands, compared to its average volume of 867,985. Pediatrix Medical Group, Inc. has a fifty-two week low of $10.06 and a fifty-two week high of $17.67. The company has a 50 day moving average of $13.67 and a 200 day moving average of $13.90. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $1.42 billion, a PE ratio of 12.62 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. During the same quarter in the prior year, the business posted $0.34 earnings per share. Pediatrix Medical Group's revenue for the quarter was down 7.1% compared to the same quarter last year. On average, equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.